Third COVID-19 vaccine dose with BNT162b2 in patients with ANCA-associated vasculitis
Claudius Speer, Maximilian Töllner, Louise Benning, Katrin Klein, Marie Bartenschlager, Christian Nußhag, Florian Kälble, Paula Reichel, Paul Schnitzler, Martin Zeier, Christian Morath, Wilhelm H. Schmitt, Raoul Bergner, Ralf Bartenschlager, Matthias Schaier
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ANCA-Associated Vasculitis2019-20 coronavirus outbreakVasculitisVirologyMEDLINEImmunologyInternal medicineInfectious disease (medical specialty)OutbreakPolitical scienceDiseaseLawVasculitis and related conditionsHeparin-Induced Thrombocytopenia and ThrombosisSARS-CoV-2 and COVID-19 Research